Trial Profile
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2024
Price :
$35
*
At a glance
- Drugs Unesbulin (Primary)
- Indications Anaplastic astrocytoma; Diffuse intrinsic pontine glioma; Glioblastoma; Glioma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 23 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2023 Planned End Date changed from 1 Jul 2028 to 1 Mar 2029.
- 28 Aug 2023 Planned primary completion date changed from 1 Jul 2023 to 1 Mar 2024.